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P2428 Pace maker infections: risk factors in a case-control
study from a cohort of 2496 patients
B. Herce, R. Sandras, P. Nazeyrollas, F. Lesaffre, A. Martin,
J.P. Chabert, H.T. Bui, S. Tassan Mangina, D. Metz. University
Hospital of Reims - Hospital Robert Debre, Reims, France
Introduction: Stimulation devices implantations, such as pacemakers (PM), have
been steadily growing in the last few years but related infections increased even
more. The objective of our study was to identify patient’s and peri-procedural risk
factors for early and late PM infection.
Methods: Our cohort included patients requiring a PM implantation between oc-
tober 1996 and july 2007. Cases were defined as PM or lead infection during
follow-up and 2 controls were matched for each case according to sex, age and
date of implantation. Data regarding patient’s conditons and heart disease, pre-
vious or concomitant invasive procedures, type of stimulating devices and post
procedural complications were prospectively recorded during this period and were
available for analysis.
Results: In our cohort 2496 primary implantations and 372 replacements were
performed. We found 35 PM related infections (infection rate 1.4% per patient,
1.2% per PM implantation) during a mean follow up of 918 days. The median de-
lay between PM implantation and infection was 86 days. A germ was identified
on culture’s device in 40% of the cases, 50% were staphylococcus aureus. PM
leads were removed percutaneously in 97% of the patients, one patient required
surgical removal. Diabetes mellitus (p=0.002), heart disease (low ejection frac-
tion, valvular disease, previous heart surgery) (p=0.047), additional procedures
related to PM implantation (temporary pacing, electrophysiological test, high fre-
quency ablation) (p=0.05), dual-chamber pacing (p=0.016) and early complica-
tions (hematoma, leads displacement), which occurred in none of the controls,
were related with PM infection in univariate analysis. Among these, diabetes mel-
litus (p=0.045; OR=3.65), history of heart disease (P=0.028; OR=3.12) and dual-
chamber pacing (p=0.021; OR=4.07), were independently associated with PM
infection.
Conclusion: in our study device infection rate was low and were related to pa-
tient’s condition (diabetes mellitus and heart disease) and periprocedural condi-
tions (local complication and dual chamber pacing).
P2429 Differences in encapsulating leads tissue in patients
who underwent transvenous leads removal
A. Kolodzinska1 , A. Kutarski2 , L. Koperski1 , M. Grabowski1 ,
G. Opolski1 . 1Medical University of Warsaw, Warsaw, Poland;
2Medical University of Lublin, Department of Cardiology, Lublin,
Poland
Introduction: Endocardial leads are encapsulated by fibrocollagenous tissue.
Features of vasculogenesis, focal infiltrates of lymphocytes, plasma cells, histi-
ocytes as well as foci of calcification can be present, sometimes hemosiderin in
macrophages and extracellularly in the connective tissue can be observed. The
aim: of our study was to characterize specific tissue reaction of encapsulating
lead tissue in patients who underwent transvenous lead removal.
Material and methods: 56 leads (27 atrial, 24 ventricular, 5 ICD) were re-
moved from 31 patients (pts) (mean age 70 years). Indications for removal
were chronic pocket infection (CPI) (9), infective endocarditis (IE) (6), non func-
tional leads (NF) (16 pts). Leads with their surrounding tissues were immediately
fixed in paraformaldehyde. Tissues were embedded in paraffin wax, stained with
hematoxylin-eosin and examined histologically. The outermost insulation leads
abrasion were examined in stereomicroscope.
Results: Mean lead age encapsulated by connective tissue sheath was 89
whereas encapsulate by granulation tissue was 47,34 months (p=0,03). Calcifica-
tion was present in 12 (%) patients. Presence of haemosiderin was observed only
in intravenous lead abrasion with perforation (29%; p=0,007) and correlated sig-
nificantly with c-reactive protein levels (p=0,001) and white blood cells (p=0,008).
Vasculogenesis was present in 1 (6%) with NF, 5 (56%) with CPI and 3 (50%)
with IE (p=0,02).
Conclusions: Granulation in encapsulating tissue were observed in pts with
younger leads. The presence of haemosiderin correlated with elevated inflamma-
tion markers. Vasculogenesis was observed more often IE and CPI what might
indicate indirectly thickness of the sheath.
P2430 The outermost silicon and polyurethane insulation
lead failure
A. Kolodzinska1 , A. Kutarski2 , M. Grabowski1 , B. Malecka3 ,
G. Opolski1 . 1Medical University of Warsaw, Warsaw, Poland;
2Medical University of Lublin, Dept. of Cardiology, Lublin, Poland;
3Dept. of Electrocardiology of Jagiellonian University of Cracow, Krakow, Poland
Polyether polyurethane (PEU) elastomers undergo biodegradation in the mech-
anism of environmental stress cracking (ESC) that concerns the outermost in-
sulation that was in direct contact with tissue, associated with macrophage and
foreign body giant cell adhesion to the device and the release of lysosomal oxi-
dants. The abrasions of the outermost silicon lead insulation might appear in the
intracardiac region, intravenous (crush syndrome) and in the pocket part of the
leads (due to friction between leads or lead and pulse generator). The aim of our
study was to determine the frequency of the outermost insulation lead damage.
Materials and methods: 301 leads (146 atrial, 113 ventricular, 31 ICD) were re-
moved from 182 patients (pts), mean pt age was 63,7 years old (range 8-89).
Reasons for removal were chronic pocket infection (CPI) (38 pts), infective en-
docarditis (IE) (32 pts), non functional leads (112 pts). The mean time from lead
implantation to removal was 81,9 months. The outermost insulation was silicon in
281 leads and polyurethane in 20 leads (ICD). The outermost leads insulations
were analyzed in stereomicroscope and scanning electron microscope.
Results: The outermost PEU ICD leads insulation were damaged in the intracar-
diac part in 18/20 (90%), intravenous 6/20 (30%), in the pocket region 3/20 (15%)
most likely in the mechanism of ESC. There were only 6/20 (30%) leads removed
due to indications associated with inflammation process (CPI or IE). There were
84 silicone outermost lead insulation abrasions with perforation. Insulation dam-
ages of atrial leads: in the intracardiac part 25 (17.1%), intravenously 3 (2,1%),
in the pocket 4 (2.7%) and ventricular leads in intracardiac 39 (34.5%), in intra-
venous 5 (4.4%) and in the pocket region 7 (6,2%) and there was in ICD lead one
case of abrasion in the intracardiac part.
Conclusions: In case of PEU insulated leads damages were observed most fre-
quently in the intracardiac part of the leads and were present mainly in patients
who underwent lead removal due to non functional lead. Abrasions of the outer-
most silicon insulation were noticed most frequently in the intracardiac part of the
lead and more often concerned ventricular leads.
P2431 Pacing in familial amyloid polyneuropathy
C. Vieira, A. Rebelo, S. Rocha, M. Torres, A. Gaspar, S. Ribeiro,
N. Salome, A. Correira. Hosp. Sao Marcos of Braga, Braga, Portugal
Introduction: Familial Amyloid Polyneuropathy (FAP) is an autoso-
mal dominant hereditary disease, which affects the peripheral ner-
vous system in its three components (motor, sensitive and autonomic). The in-
volvement of the autonomic nervous system as well as myocardial infiltration can
result in various manifestations of cardiovascular disease. The most common of
those manifestations are changes in atrio-ventricular conduction and sinus node
disease. This explains why many of the patients (P) with FAP need permanent
pacemaker (PM). In the subgroup of P awaiting liver transplantation, the indica-
tions for PM implantation are broader than those used for the general.
Objective: To characterize a population with FAP, assess the main indications for
PM implantation and describe the evolution of these P.
Population and Methods: Review of all clinical processes of P with FAP who
underwent implantation of PM in our hospital.
Results: We evaluated 26 P, 15 females (57.7%), with a mean age of 49.5±10.6
years. Two P were first-degree relatives and 4 were second-degree relatives. The
mean age of implantation of PM was 45.5±10.9 years. The main indications for
implantation were: atrio-ventricular complete blockade (11P), patients on the wait-
ing list for liver transplantation (4P) and sinus node disease (4P). The modes of
PM implanted were DDDR (7P), DDD (5P), VDDR (3P), VVI (7P) and VVIR (4P).
The median follow-up was 51.0 months (interquartile range P25: 22.8 months and
P75: 89.5 months). The average number of visits was 9.6±6.8, and they had an
average of 2.9±2.9 visits per year. In 6 P (23%) there was a need for changing
the pacemaker mode because of development of atrial fibrillation (4P), atrial flut-
ter (1P) and brady-tachycardia syndrome (1P). The mortality rate was 38.5%. It
happened in average 18.0±35.0 months after implantation of PM. None of the
transplanted patients died so far.
Conclusion: This study shows that this population develops cardiac brad-
yarrhythmias with indication for PM at a younger age than the general population,
implying a close and early screnning of these P. Furthermore, in 23% of P there
was the need of changing pacemaker mode because of new changes in heart
rhythm. This shows the progressive nature of the arrhythmias in this population
and points to the need for periodic monitoring of these P. According to this study,
liver transplanted patients seem to have an overall better outcome.
P2432 RV threshold behavior: the role of algorithms for
automatic verification of stimulation
M. Biffi, M. Bertini, V. Mantovani, A. Mazzotti, B. Gardini, M. Ziacchi,
I. Diemberger, C. Martignani, C. Moschini, G. Boriani. Institute of
Cardiology, Bologna, Italy
Purpose: Long term (>1 year) behaviour of RV pacing threshold has never been
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